Oligodendrogliomas Terminated Phase 2 Trials for 6-O-benzylguanine (DB11919)

Also known as: Oligodendroglioma / [M]Oligodendroglioma NOS / Oligodendroglioma, Well-Differentiated

IndicationStatusPhase
DBCOND0032978 (Oligodendrogliomas)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00389090A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaTreatment